Metal injection molding (MIM) specialist Phillips-Medisize Corporation has acquired Medicom Innovation Partner, a provider of device strategy, product design and development services with a focus on personal drug delivery device for biopharma and specialty pharmaceuticals.
Together, the combined company will have over 500 engineers across facilities in the US, the Netherlands, Denmark, the UK and China.
‘This transaction is consistent with our strategic focus on serving the rapidly growing diabetes, biologics, specialty pharmaceutical and personalized oncology markets that need these products and reinforces our leading position in drug delivery device solutions,’ said Matt Jennings, chairman, CEO and president of Phillips-Medisize.
This story is reprinted from material from Phillips-Medisize, with editorial changes made by Materials Today. The views expressed in this article do not necessarily represent those of Elsevier.